Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nihon Chouzai Co ( (JP:3341) ) just unveiled an announcement.
Nihon Chouzai Co., Ltd. reported a significant improvement in its financial performance for the first quarter of the fiscal year ending March 31, 2026, with net sales increasing by 8.9% year-on-year to 94,155 million yen. The company also saw a substantial rise in EBITDA by 89.9%, reflecting a strong operational performance. However, the company announced a revision in its dividend forecast, indicating no dividends for the fiscal year, which may impact shareholder returns.
More about Nihon Chouzai Co
Nihon Chouzai Co., Ltd. operates in the healthcare industry, primarily focusing on pharmaceutical services and products. The company is listed on the Tokyo Stock Exchange and is involved in providing a range of healthcare solutions.
Average Trading Volume: 200,491
Technical Sentiment Signal: Buy
Current Market Cap: Yen97.25B
See more insights into 3341 stock on TipRanks’ Stock Analysis page.